NewsPeople with SARS-CoV-2 Antibodies May Be Protected against ReinfectionNational Cancer Institute, National Institutes of Health | February 24, 2021 The new findings may explain why reinfection with the novel coronavirus appears to be relatively rare
NewsDifferences in Antibody Response May Drive COVID-19 OutcomesMassachusetts General Hospital | February 19, 2021 Study identifies the specific types of antibodies that may be driving COVID-19 outcomes in both children and adults
NewsAntibodies to Common Cold Coronaviruses Do Not Protect against SARS-CoV-2University of Pennsylvania School of Medicine | February 10, 2021 Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 do not neutralize the COVID-19-causing virus
NewsNew Biosensors Quickly Detect Coronavirus Proteins and AntibodiesUniversity of Washington Health Sciences, UW Medicine | February 2, 2021 Researchers have designed protein-based biosensors that glow when in contact with the virus or COVID-19 antibodies
NewsNew Promising Antibodies against SARS-CoV-2University of Bonn | January 14, 2021 The novel antibodies, called nanobodies, attack different parts of the coronavirus simultaneously
NewsCOVID-19 Severity Affected by Amount of Antibodies Targeting Spike ProteinStanford Medicine | December 25, 2020 Mild cases of COVID-19 have more antibodies that target the novel coronavirus's spike protein than severe cases do
NewsResearch Reveals Compromised Transfer of COVID-19 Antibodies through PlacentaMassachusetts General Hospital | December 24, 2020 Glycosylation of SARS-CoV-2-specific antibodies may be to blame for this reduced transfer from mother to fetus
NewsNew Serological Assay Provides Rapid, Accurate Testing for SARS-CoV-2 AntibodiesUniversity of California - Santa Cruz | December 12, 2020 Using optical biosensor technology, the test provides quantitative measurements of antibodies in less than 20 minutes
Product NewsHeparan Sulfate Products for COVID-19 Infection, Disease, & Therapeutics ResearchAMSBIO | November 24, 2020 Heparan sulfate is increasingly recognized as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 coronavirus pandemic
NewsPre-existing Coronavirus Antibodies Could Help Protect against COVID-19The Francis Crick Institute | November 10, 2020 Antibodies created in response to common cold coronaviruses can target a subunit of the SARS-CoV-2 spike protein